Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
Steven P. Grover,Nigel Mackman +1 more
Reads0
Chats0
TLDR
The roles of TF in protective hemostasis and pathological thrombosis are focused on and coagulation proteases, such as FVIIa, FXa, and thrombin are described.Abstract:
Tissue factor (TF) is the high-affinity receptor and cofactor for factor (F)VII/VIIa The TF-FVIIa complex is the primary initiator of blood coagulation and plays an essential role in hemostasis TF is expressed on perivascular cells and epithelial cells at organ and body surfaces where it forms a hemostatic barrier TF also provides additional hemostatic protection to vital organs, such as the brain, lung, and heart Under pathological conditions, TF can trigger both arterial and venous thrombosis For instance, atherosclerotic plaques contain high levels of TF on macrophage foam cells and microvesicles that drives thrombus formation after plaque rupture In sepsis, inducible TF expression on monocytes leads to disseminated intravascular coagulation In cancer patients, tumors release TF-positive microvesicles into the circulation that may contribute to venous thrombosis TF also has nonhemostatic roles For instance, TF-dependent activation of the coagulation cascade generates coagulation proteases, such as FVIIa, FXa, and thrombin, which induce signaling in a variety of cells by cleavage of protease-activated receptors This review will focus on the roles of TF in protective hemostasis and pathological thrombosisread more
Citations
More filters
Journal Article
International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS)
Journal ArticleDOI
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.
Eugenio D. Hottz,Eugenio D. Hottz,Isaclaudia G. de Azevedo-Quintanilha,Lohanna Palhinha,Lívia Teixeira,Ester A. Barreto,Camila R. R. Pão,Cassia Righy,Sérgio Franco,Thiago Moreno L. Souza,Pedro Kurtz,Fernando A. Bozza,Patrícia T. Bozza +12 more
TL;DR: It is demonstrated that increased platelet activation and platelet-monocyte aggregate formation are observed in severe COVID-19 patients, but not in patients presenting mild CO VID-19 syndrome, and these data shed light on new pathological mechanisms involving plateletactivation and Platelet-dependent monocyte TF expression, which were associated with COVID -19 severity and mortality.
Journal ArticleDOI
The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease
TL;DR: It is proposed that subtle asymptomatic alterations in lymphatic vascular function could underlie the variability seen in the body's response to a wide range of human diseases.
Journal ArticleDOI
Inflammasome activation triggers blood clotting and host death through pyroptosis
Congqing Wu,Wei Lu,Yan Zhang,Guoying Zhang,Xuyan Shi,Yohei Hisada,Steven P. Grover,Xinyi Zhang,Lan Li,Binggang Xiang,Jumei Shi,Xiang-An Li,Alan Daugherty,Susan S. Smyth,Daniel Kirchhofer,Toshihiko Shiroishi,Feng Shao,Nigel Mackman,Yinan Wei,Zhenyu Li +19 more
TL;DR: It is shown that canonical inflammasome activation by the conserved type III secretion system (T3SS) rod proteins from Gram-negative bacteria or noncanonical inflammaomeactivation by lipopolysaccharide (LPS) induced systemic blood clotting and massive thrombosis in tissues.
Journal ArticleDOI
An aberrant STAT pathway is central to COVID-19
Toshifumi Matsuyama,Shawn P. Kubli,Steven Kiyoshi Yoshinaga,Klaus Pfeffer,Tak W. Mak,Tak W. Mak,Tak W. Mak +6 more
TL;DR: To enhance STAT1 activity and/or inhibit STAT3 functions for COVID-19 treatment is suggested, which might derail the escalating STAT3/PAI-1 cycle central to CO VID-19.
References
More filters
Journal ArticleDOI
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
Spiros Miyakis,Michael D. Lockshin,Tatsuya Atsumi,D W Branch,Robin L. Brey,Ricard Cervera,R. H. W. M. Derksen,P. G. De Groot,Takao Koike,Pier Luigi Meroni,Guido Reber,Yehuda Shoenfeld,Angela Tincani,Panayiotis G. Vlachoyiannopoulos,Steven A. Krilis +14 more
TL;DR: This document appraise the existing evidence on clinical and laboratory features of APS addressed during the forum and proposes amendments to the Sapporo criteria, including definitions on features ofAPS that were not included in the updated criteria.
Journal ArticleDOI
Thrombin signalling and protease-activated receptors
TL;DR: Roles for PARs are beginning to emerge in haemostasis and thrombosis, inflammation, and perhaps even blood vessel development.
Journal ArticleDOI
A cell-based model of hemostasis
TL;DR: This model emphasizes the importance of specific cellular receptors for the coagulation proteins and explains some aspects of hemostasis that a protein-centric model does not.
Journal ArticleDOI
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
TL;DR: This study showed no significant differences in baseline CEC counts or VWF levels between the AR, CS and RFV, however, PCI was associated with a significant increase in CECs, but not VWF, across all three sampling sites, and this study cannot presume that the increased CEC numbers represent specific coronary artery endothelial shedding.
Related Papers (5)
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
Marie-Luise von Brühl,Konstantin Stark,Alexander Steinhart,Sue Chandraratne,Ildiko Konrad,Michael Lorenz,Alexander G. Khandoga,Anca Tirniceriu,Raffaele Coletti,Maria Köllnberger,Robert A. Byrne,Iina Laitinen,Axel Walch,Alexander Brill,Susanne Pfeiler,Davit Manukyan,Siegmund Braun,Philipp S. Lange,Julia Riegger,Jerry Ware,Annekathrin Eckart,Selgai Haidari,Martina Rudelius,Christian Schulz,Katrin Echtler,Volker Brinkmann,Markus Schwaiger,Klaus T. Preissner,Denisa D. Wagner,Nigel Mackman,Bernd Engelmann,Steffen Massberg +31 more